Spot Trading’s Immunic IMUX Stock Holding History

Spot Trading’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-200	Closed	-$922K	–	3677
2015 Q4	$922K	Buy	200 +180	+900%	+$587K	0.01%	1513
2015 Q3	$33K	Buy	+20	New	+$100K	﹤0.01%	3393

Other funds holding IMUX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Spot Trading's IMUX Position: Q1 2016 in Review

Spot Trading sold out of Immunic (IMUX) in Q1 2016, closing a stake of 32 shares — an estimated $147K sold.

Spot Trading first reported a position in IMUX in Q3 2015 and held it in 2 quarters. The position peaked at $147K in Q4 2015. 52 funds tracked by Wall St. Rank hold IMUX as of Q1 2016.

Spot Trading reported no remaining Immunic position as of Q1 2016 after selling out during the quarter.
Spot Trading sold 32 Immunic shares in Q1 2016, an estimated $147K.
Spot Trading first reported a position in Immunic in Q3 2015 and held it in 2 quarters.
Spot Trading's Immunic position peaked at $147K in Q4 2015.
52 funds tracked by Wall St. Rank held Immunic as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.